Effects of Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy
Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Aug 15, 2025
Trial Information
Current as of November 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of therapy using virtual reality (VR) to help people recover movement in their arms after a stroke. The researchers want to see if a special VR therapy that involves using both hands together to complete tasks (called Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy) works better than traditional VR mirror therapy, which focuses on one hand at a time. They will look at how these therapies improve arm function and brain activity in people who have had a stroke on one side of their body.
To join this study, participants need to have had a stroke affecting one side of their body at least six months ago, be right-handed before their stroke, and have good mental function (tested by a simple mental exam). People with serious vision problems, major thinking or perception difficulties, or other brain diseases cannot take part. If you join, you can expect to participate in VR therapy sessions where you’ll perform tasks designed to help improve arm movement while the therapy tracks and supports your progress. This study is not yet recruiting participants, but it aims to find better ways to help stroke survivors regain arm use and improve their quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of stroke with unilateral side involved;
- • A score of Mini-mental state examination greater than 24 for proving higher mental function
- • Time of onset \> 6 months before treatment begins; and
- • Premorbid right-handedness.
- Exclusion Criteria:
- • Severe vision impairment;
- • Major cognitive-perceptual deficit;
- • Other brain disease.
About National Cheng Kung University Hospital
National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tainan, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported